Panacea Index Logo

Command Palette

Search for a command to run...

Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience.

Neurogastroenterology and motility
January 1, 2020
Caroline J Tuck et al. (4 authors)
Journal ArticleResearch Support, Non-U.S. Gov'tHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the real-world adherence and effectiveness of the low-FODMAP diet for functional gastrointestinal symptoms when recommended by different healthcare providers.

Results Summary

55% of patients reported ≥50% symptom improvement, but compliance was poor in Phases 2 and 3 without dietitian guidance, and only 44% achieved the therapeutic FODMAP intake target.

Population

Functional gastrointestinal disorder (FGID) patients attending a gastroenterology clinic (n=80, 21 male).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low FODMAP diet
decrease
functional gastrointestinal symptoms
FGID patients
-
reduces
#1
low FODMAP diet
increase
symptom improvement
FGID patients attending a gastroenterology clinic
≥50%
reported
#2
low FODMAP diet
increase
Phase-1
FGID patients attending a gastroenterology clinic
78%
followed appropriately
#3
low FODMAP diet
increase
Phase-2
FGID patients attending a gastroenterology clinic
48%
followed appropriately
#4
low FODMAP diet
increase
Phase-3
FGID patients attending a gastroenterology clinic
40%
followed appropriately
#5
low FODMAP diet
decrease
FODMAP intake
FGID patients attending a gastroenterology clinic
<12 g/d
achieved
#6
dietitian guidance
increase
compliance
FGID patients attending a gastroenterology clinic
-
improved
#7
Abstract

BACKGROUND: The low FODMAP (fermentable oligo-, di-, monosaccharides, and polyols) diet reduces functional gastrointestinal symptoms (FGID) when implemented by dietitian-delivered education in clinical trials, but it is unknown how well the diet is followed in routine clinical care and if differences exist when implemented by physician or dietitian. This study aimed to evaluate the real-world experience of patients recommended the diet. METHODS: This case-series interviewed FGID patients attending a gastroenterology clinic with previous recommendation to trial the low FODMAP diet, examining who recommended the diet and what their percentage improvement was. To evaluate implementation of the diet's 3 phases, questions were constructed based on current literature and clinical guidelines regarding length of initial restriction and food knowledge (Phase-1), number of foods re-challenged (Phase-2) and food re-introduction as tolerated (Phase-3). The comprehensive nutrition assessment questionnaire provided daily FODMAP intake. Data were analyzed using chi-squared tests. KEY RESULTS: In 80 patients (21 male), the diet was recommended by the gastroenterologist in 53%, general practitioner 22%, dietitian 9% and other 15%. 30% saw a dietitian for guidance. 55% reported a ≥50% symptom improvement. The diet was followed appropriately during Phase-1 by 78% (with vs without a dietitian, 96% vs 71%; P = .02), Phase-2 by 48% (70% vs 39%; P = .02) and Phase-3 by 40% (65% vs 29%; P < .01). A FODMAP intake of <12 g/d (considered therapeutic) was achieved by 44% (72% vs 31%; P < .01). CONCLUSIONS & INFERENCES: Symptom improvement was reported in half of patients, but many did not reach the therapeutic FODMAP intake target, especially without dietitian education. Compliance was poor in Phase-2 and Phase-3 but improved with dietitian guidance.

Medical Subject Headings (MeSH)
AdultAgedDiet, Carbohydrate-RestrictedFemaleGastrointestinal DiseasesHumansMaleMiddle AgedPatient ComplianceTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality65/10
Citation Metrics
Total Citations57
Citations/Year11.4
Relative Citation Ratio4.92
NIH Percentile92.9%
Research Impact Scores
APT Score0.95
Weight Score2.32
Normalized Score0.61
Related Supplements